Privo Technologies is revolutionizing the treatment of oral cancer. In the US, oral cancer kills one person per hour per day. Current Care focuses on IV Cisplatin, which has significant toxicity to the body. Our solution, Novel Chemotherapy Wafer, is a local treatment, highly efficient while overcoming chemo resistance issues, reducing toxicity, improving patient compliance, and reducing or delaying the need for surgery.
Connect with Privo Technologies